regulatory
confidence high
sentiment negative
materiality 0.60
Plus Therapeutics gets Nasdaq extension until May 11, 2026 to regain $1 bid price
PLUS THERAPEUTICS, INC.
- Received 180-day extension to May 11, 2026 from Nasdaq to meet $1.00 minimum bid price rule.
- No immediate effect on listing; stock continues trading on Nasdaq under PSTV.
- If bid price closes at $1.00+ for 10 consecutive days, compliance confirmed and matter closed.
- Company may implement reverse stock split if needed; no guarantee of regaining compliance.